U.S., TPP Countries Scramble To Find Compromise On Biologics Data Exclusivity

LAHAINA, Hawaii -- The United States and other Trans Pacific Partnership (TPP) countries are scrambling here to find a compromise on the controversial issue of data exclusivity for biologic drugs that would appease Australia's demand that a final deal not require a change to its domestic law on this issue. Australia's law provides five years of data exclusivity for all medicines and does not have specific provisions for biologics. The compromise proposal under discussion appears to involve setting a base...